The PI3K-Akt-GSK-3 pathway was reported to be insensitive in peripheral blood mononuclear cells of AMD patients and in cultured RPE cells (Busch et al., 2017; Liu and Yao, 2017; Zheng et al., 2018). Here, AKT1 is linked to age-related macular degeneration.